Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On January 7, 2026, Ventyx Biosciences, Inc. (the “Company”), entered into an Agreement
of this Current Report on Form 8-K, including the information incorporated by reference from Exhibit 99.1 hereto this report, shall not be deemed to be incorpor
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 2.1* Agreement and Plan of Merger, dated as of January 7, 2026, by and among Eli Lilly